Role of CD147 in the development and diagnosis of hepatocellular carcinoma
- PMID: 37090718
- PMCID: PMC10115957
- DOI: 10.3389/fimmu.2023.1149931
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and the third leading cause of cancer-related deaths worldwide. HCC is characterized by insidious onset, and most patients are diagnosed at an advanced stage with a poor prognosis. Identification of biomarkers for HCC onset and progression is imperative to development of effective diagnostic and therapeutic strategies. CD147 is a glycoprotein that is involved in tumor cell invasion, metastasis and angiogenesis through multiple mechanisms. In this review, we describe the molecular structure of CD147 and its role in regulating HCC invasion, metastasis and angiogenesis. We highlight its potential as a diagnostic and therapeutic target for HCC.
Keywords: CD147; angiogenesis; diagnosis; hepatocellular carcinoma; metastasis.
Copyright © 2023 Huang, Rao, Jin, Lai, Zhang, Lai, Shen and Zhong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.Cell Oncol (Dordr). 2019 Aug;42(4):537-554. doi: 10.1007/s13402-019-00444-0. Epub 2019 Apr 23. Cell Oncol (Dordr). 2019. PMID: 31016558
-
Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.J Gastroenterol Hepatol. 2016 Feb;31(2):459-66. doi: 10.1111/jgh.13148. J Gastroenterol Hepatol. 2016. PMID: 26312403
-
Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.J Cell Mol Med. 2011 Jun;15(6):1415-28. doi: 10.1111/j.1582-4934.2010.01124.x. Epub 2010 Jul 12. J Cell Mol Med. 2011. PMID: 20629990 Free PMC article.
-
Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.Life Sci. 2019 Aug 15;231:116660. doi: 10.1016/j.lfs.2019.116660. Epub 2019 Jul 15. Life Sci. 2019. PMID: 31319086 Review.
-
Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma.Mol Med. 2023 Oct 17;29(1):136. doi: 10.1186/s10020-023-00731-5. Mol Med. 2023. PMID: 37848835 Free PMC article. Review.
Cited by
-
Hydrogen Sulfide Modulation of Matrix Metalloproteinases and CD147/EMMPRIN: Mechanistic Pathways and Impact on Atherosclerosis Progression.Biomedicines. 2024 Aug 26;12(9):1951. doi: 10.3390/biomedicines12091951. Biomedicines. 2024. PMID: 39335465 Free PMC article. Review.
-
Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility.Int J Mol Sci. 2023 Jul 17;24(14):11544. doi: 10.3390/ijms241411544. Int J Mol Sci. 2023. PMID: 37511303 Free PMC article. Review.
-
Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma.Virchows Arch. 2025 Jul;487(1):117-125. doi: 10.1007/s00428-024-03939-w. Epub 2024 Oct 12. Virchows Arch. 2025. PMID: 39395054
-
TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.Int J Biol Sci. 2024 Apr 8;20(6):2297-2309. doi: 10.7150/ijbs.93667. eCollection 2024. Int J Biol Sci. 2024. PMID: 38617545 Free PMC article.
-
Serum-biomarker-based population screening model for hepatocellular carcinoma.iScience. 2025 Feb 8;28(3):111981. doi: 10.1016/j.isci.2025.111981. eCollection 2025 Mar 21. iScience. 2025. PMID: 40060905 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical